STOCK TITAN

ZOAR Stock Price, News & Analysis

ZOAR NYSE
Published by Stock Titan Data refreshed

Why is ZOAR Stock Down Today?

27.70% today
12 alerts
15m delay

Zoar Limited’s completed business combination with Impact Biomedical was announced on November 18, the day before today’s trading. After closing, Zoar had approximately 180.0 million ordinary shares outstanding, and Dr. Kanans Visvanats held approximately 93.32%.

AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.

What Changed

Company Description

Zoar (NYSE: ZOAR) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $831.6M.

This page collects what Stock Titan holds for ZOAR, including price data and latest news.

Stock Performance

$4.62
-27.70%
-1.77
Last updated: at
-
Performance 1 year
$831.6M

ZOAR Metrics & Rankings

Latest News

Zoar has 1 recent news article, with the latest published on . Key topics include acquisition. View all ZOAR news →

SEC Filings

No SEC filings available for ZOAR.

ZOAR Company Profile & Sector Positioning

Zoar (ZOAR) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the NYSE.

Frequently Asked Questions

The market cap of Zoar (ZOAR) is approximately $831.6M. Learn more about what market capitalization means .